Monday, February 05, 2024 3:56:28 PM
SOHM, Inc.
@sohminc
We are excited to announce that our company will participate in the American Association for Cancer Research (AACR) annual meeting in San Diego from April 5 to April 10, 2024.
At this internationally attended meeting, we will present our innovative gene-editing system, ABBIE, and its potential in cancer research to the scientific community and media covering the conference.
The abstract of our poster presentation will be published on the AACR website (http://aacr.org) on March 22, 2024.
Our preliminary focus in this project is cancer, but our technology has utilities in many areas of medicine and bioscience where genome editing has great potential. As we progress in this work, we plan to add highly significant research and product developments for various industries in biotech, medicine and agriculture.
We are very proud of our company’s progress to date, our entire research team, including but not limited to Dr. David Aguilar, PhD and our Research Scientist, Alfred Gallegos, and our contributions to genome editing, cell engineering, and the biomedical and other biotech sectors.
Baron Night
CEO
$SHMN
Recent SHMN News
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM